Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5476
PUT
Live Nation Entertainment
LYV
$40.6B
| $86K | ﹤0.01% |
1,300
-5,700
| -81% | -$399K |
|
|
SBT
5477
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $86K | ﹤0.01% |
8,781
-10,655
| -55% | -$104K |
|
|
AJRD
5478
PUT
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $86K | ﹤0.01% |
1,700
+1,400
| +467% | +$68K |
|
|
ATHX
5479
DELISTED
Athersys, Inc. Common Stock
ATHX
| $86K | ﹤0.01% |
2,573
-729
| -22% | -$25.8K |
|
|
BPT
5480
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $85K | ﹤0.01% |
9,300
-4,000
| -30% | -$41.3K |
|
5481
PUT
Consolidated Edison
ED
$40.1B
| $85K | ﹤0.01% |
900
-100
| -10% | -$8.88K |
|
5482
CALL
IAMGOLD
IAG
$8.2B
| $85K | ﹤0.01% |
24,900
-6,700
| -21% | -$24.1K |
|
5483
IES Holdings
IESC
$14.8B
| $85K | ﹤0.01% |
4,099
-1,222
| -23% | -$23.2K |
|
|
KZR
5484
DELISTED
Kezar Life Sciences
KZR
| $85K | ﹤0.01% |
2,594
+90
| +4% | +$4.34K |
|
5485
Preformed Line Products
PLPC
$1.75B
| $85K | ﹤0.01% |
1,565
-479
| -23% | -$25.7K |
|
5486
Superior Group of Companies
SGC
$185M
| $85K | ﹤0.01% |
5,280
-1,661
| -24% | -$25.9K |
|
|
UBX
5487
DELISTED
Unity Biotechnology
UBX
| $85K | ﹤0.01% |
1,397
-1,205
| -46% | -$85.2K |
|
|
BID
5488
CALL
DELISTED
Sotheby's
BID
| $85K | ﹤0.01% |
1,500
-3,100
| -67% | -$180K |
|
5489
CALL
Banner Corp
BANR
$2.39B
| $84K | ﹤0.01% |
1,500
+1,000
| +200% | +$55.2K |
|
5490
PUT
Enovis
ENOV
$1.68B
| $84K | ﹤0.01% |
1,685
+407
| +32% | +$19.2K |
|
5491
Genmab
GMAB
$17.7B
| $84K | ﹤0.01% |
+4,183
| New | +$82.4K |
|
|
NOA
5492
North American Construction
NOA
$369M
| $84K | ﹤0.01% |
7,300
-2,306
| -24% | -$26.4K |
|
5493
BlackRock TCP Capital
TCPC
$273M
| $84K | ﹤0.01% |
+6,243
| New | +$86K |
|
|
FCCY
5494
DELISTED
1st Constitution Bancorp
FCCY
| $84K | ﹤0.01% |
4,483
-508
| -10% | -$9.08K |
|
|
CHMA
5495
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $84K | ﹤0.01% |
16,888
-6,097
| -27% | -$34.6K |
|
|
PGNX
5496
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $84K | ﹤0.01% |
16,600
+11,300
| +213% | +$56.4K |
|
5497
PUT
Albemarle
ALB
$13.9B
| $83K | ﹤0.01% |
1,200
-50,000
| -98% | -$3.41M |
|
5498
Princeton Bancorp
BPRN
$281M
| $83K | ﹤0.01% |
2,874
-916
| -24% | -$25.5K |
|
|
CASI
5499
DELISTED
CASI Pharmaceuticals
CASI
| $83K | ﹤0.01% |
2,486
-765
| -24% | -$24.6K |
|
5500
eGain
EGAN
$187M
| $83K | ﹤0.01% |
10,388
-10,019
| -49% | -$76.7K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.